TOPOMETRIC PREPARATION AND PLANNING OF NEOADJUVANT RADIOTHERAPY IN THE COMPLEX TREATMENT OF RECTAL CANCER
DOI:
https://doi.org/10.34287/MMT.3(54).2022.8Abstract
Objective(s). To evaluate the effectiveness of the use of topometry during neoadjuvant radiation therapy in the complex treatment of rectal cancer.
Methods. The results of treatment of 113 patients with locally advanced rectal cancer (cT3c-4N1-2M0) were analyzed. The patients were divided into two groups: the first (main) group included 57 patients who received only a course of neoadjuvant radiation therapy as part of the neoadjuvant stage of treatment. The second group (control group) included 56 patients who underwent a course of radiation therapy with capecitabine potentiation. Topometric preparation, contouring of irradiated volumes, critical structures and radiation treatment of all patients included in the study were carried out according to standard principles and started 5 days before its implementation.
Results. When comparing the results of MRI performed before the beginning and after the end of the radiation therapy course in 102 (90.2%) of 113, a positive trend was noted in the form of a decrease in the length of the tumor itself and an increase in the distance between the tumor and the anal edge, p=0.0001. No statistically significant differences were found when evaluating the influence of criteria of intragroup effects on the reduction of tumor length when choosing fractionation modes.
Conclusions. In 52 (91.2%) patients of the main group and 51 (911%) of the control group had a positive CRM status. Analysis of CRM status in patients before and after the end of the course of neoadjuvant radiation therapy showed positive dynamics, both in the main and in the control group (p<0.000). After a prolonged course of neoadjuvant radiation therapy, the number of patients with a positive CRM status decreased to 17 (30%) in the main group and 19 (34%) in the control group (p<0.000). According to the MRI results performed before and after the course of neoadjuvant radiation therapy in 102 (90.2%) out of 113, positive dynamics were noted in the form of a decrease in the length of the tumor itself and an increase in the distance between the tumor and the anal edge, p=0, 0001.
References
Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V, Sartoretti P, Dousset B, Majno PE, Soubrane O, Chaussade S. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery. Annals of oncology. 2007 Feb 1;18(2):299-304.
Baumann M, Krause M, Overgaard J, Debus J, Bentzen SM, Daartz J, Richter C, Zips D, Bortfeld T. Radiation oncology in the era of precision medicine. Nature Reviews Cancer. 2016 Apr;16(4):234-49.
Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, Cohen S, Cooper HS, Deming D, Engstrom PF, Grem JL. Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network. 2018 Jul 1;16(7):874-901.
Dapper H, Oechsner M, Münch S, Borm K, Peeken J, Mayinger M, Combs SE, Habermehl D. Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer. Radiation Oncology. 2018 Dec;13(1):1-8.
Dapper H, Rodríguez I, Münch S, Peeken JC, Borm K, Combs SE, Habermehl D. Impact of VMAT-IMRT compared to 3D conformal radiotherapy on anal sphincter dose distribution in neoadjuvant chemoradiation of rectal cancer. Radiation Oncology. 2018 Dec;13(1):1-9.
Ng SY, Colborn KL, Cambridge L, Hajj C, Yang TJ, Wu AJ, Goodman KA. Acute toxicity with intensity modulated radiotherapy versus 3-dimensional conformal radiotherapy during preoperative chemoradiation for locally advanced rectal cancer. Radiotherapy and Oncology. 2016 Nov 1;121(2):252-7.
Prescribing IC. recording and reporting photon beam therapy (supplement to ICRU report 50). ICRU report. 1999;62.
Van der Valk MJ, Hilling DE, Bastiaannet E, Kranenbarg EM, Beets GL, Figueiredo NL, Habr-Gama A, Perez RO, Renehan AG, van de Velde CJ, Ahlberg M. Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. The Lancet. 2018 Jun 23;391(10139):2537-45.
Youssef FF, Parikh PJ, DeWees TA, Mutch MG, Tan Jr BR, Grigsby PW, Myerson RJ, Olsen JR. Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy. Advances in radiation oncology. 2016 Apr 1;1(2):94-100.
Wen G, Zhang J, Chi F, Chen L, Huang S, Niu S, Gao Y, Wen B, Zhang Y. Dosimetric comparison of volumetric modulated arc therapy (VMAT), 5F Intensity Modulated Radiotherapy (IMRT) and 3D conformal radiotherapy (3DCRT) in rectal carcinoma receiving neoadjuvant chemoradiotherapy. International Journal of Medical Physics, Clinical Engineering and Radiation Oncology. 2015 Jan 16;4(01):54.
